Anavex Life Sciences Corp (AVXL)

[RedShoulder]

FDA: "In addition, after initial dialogue, the U.S. FDA’s Center for Drug Evaluation and Research (CDER) advised the Company to request a meeting to discuss the Company’s Alzheimer's disease clinical trial results."

https://www.anavex.com/post/anavex-life-sciences-provides-regulatory-update-on-blarcamesine-for-early-alzheimer-s-disease